Epistasis among Deleterious Mutations in the HIV-1 Protease

被引:23
|
作者
Parera, Mariona [1 ]
Perez-Alvarez, Nuria [2 ,3 ]
Clotet, Bonaventura [1 ,2 ]
Angel Martinez, Miguel [1 ]
机构
[1] Univ Autonoma Barcelona, Fundacio irsiCaixa, Badalona, Spain
[2] Hosp Univ Germans Trias i Pujol, Lluita SIDA Fdn, Badalona, Spain
[3] Tech Univ Catalonia, Stat & Operat Res Dept, Barcelona, Spain
关键词
epistasis; mutation; fitness; HIV-1; protease; IMMUNODEFICIENCY-VIRUS TYPE-1; GENETIC SCREEN; COMPENSATORY MUTATIONS; SYNERGISTIC EPISTASIS; CATALYTIC EFFICIENCY; FITNESS LANDSCAPE; IN-VIVO; EVOLUTION; ROBUSTNESS; RECOMBINATION;
D O I
10.1016/j.jmb.2009.07.015
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A central goal in molecular evolution is to understand how genetic interactions between protein mutations shape protein function and fitness. While intergenic epistasis has been extensively explored in eukaryotes, bacteria, and viruses, intragenic epistatic interactions have been insufficiently studied. Here, we employ a model system in which lambda phage fitness correlates with the enzymatic activity of human immunodeficiency virus type 1 (HIV-1) protease to systematically determine the epistatic interactions between intragenic pairs of deleterious protein substitutions. We generated 114 genotypes of the HIV-1 protease, each carrying pairs of nucleotide substitution mutations whose separated and combined deleterious effects on fitness were then determined. A high proportion (39%) of pairs displayed lethality. Several pairs exhibited significant interactions for fitness, including positive and negative epistasis. Significant negative epistatic interactions predominated (15%) over positive interactions (2%). However, the average +/- SD epistatic effect, (e) over bar = 0.0025 +/- 0.1334, was not significantly different from zero (p = 0.8368). Notably, epistatic interactions, regardless of epistatic direction, tend to be more frequent in the context of less deleterious mutations. In the present study, the high frequencies of lethality and negative epistasis indicate that the HIV-1 protease is highly sensitive to the effects of deleterious mutations. Therefore, proteins may not be as robust to mutational change as is usually expected. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:243 / 250
页数:8
相关论文
共 50 条
  • [1] Predominance of positive epistasis among drug resistance-associated mutations in HIV-1 protease
    Zhang, Tian-hao
    Dai, Lei
    Barton, John P.
    Du, Yushen
    Tan, Yuxiang
    Pang, Wenwen
    Chakraborty, Arup K.
    Lloyd-Smith, James O.
    Sun, Ren
    PLOS GENETICS, 2020, 16 (10):
  • [2] Epistasis as a Determinant of the HIV-1 Protease's Robustness to Mutation
    Capel, Elena
    Parera, Mariona
    Angel Martinez, Miguel
    PLOS ONE, 2014, 9 (12): : e116301
  • [3] HIV-1 Protease Mutations and Protease Inhibitor Cross-Resistance
    Rhee, Soo-Yon
    Taylor, Jonathan
    Fessel, W. Jeffrey
    Kaufman, David
    Towner, William
    Troia, Paolo
    Ruane, Peter
    Hellinger, James
    Shirvani, Vivian
    Zolopa, Andrew
    Shafer, Robert W.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (10) : 4253 - 4261
  • [4] Testing for epistasis between deleterious mutations
    West, SA
    Peters, AD
    Barton, NH
    GENETICS, 1998, 149 (01) : 435 - 444
  • [5] Mutations in HIV-1 gag cleavage sites and their association with protease mutations
    Koch, N
    Yahi, N
    Fantini, J
    Tamalet, C
    AIDS, 2001, 15 (04) : 526 - 528
  • [6] Evidence for positive epistasis in HIV-1
    Bonhoeffer, S
    Chappey, C
    Parkin, NT
    Whitcomb, JM
    Petropoulos, CJ
    SCIENCE, 2004, 306 (5701) : 1547 - 1550
  • [7] Combining mutations in HIV-1 protease to understand mechanisms of resistance
    Mahalingam, B
    Boross, P
    Wang, YF
    Louis, JM
    Fischer, CC
    Tozser, J
    Harrison, RW
    Weber, IT
    PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2002, 48 (01) : 107 - 116
  • [8] Impact of gag mutations on selection of darunavir resistance mutations in HIV-1 protease
    Marcelin, A. G.
    Lambert-Niclot, S.
    Canestri, A.
    Soulie, C.
    Wirden, M.
    Tubiana, R.
    Cheret, A.
    Katlama, C.
    Flandre, P.
    Calvez, V.
    ANTIVIRAL THERAPY, 2008, 13 (04) : A51 - A51
  • [9] Effect of distal mutations on the molecular dynamics of the HIV-1 protease
    Kovalskyy, DB
    Dubina, VM
    Mark, AE
    Kornelyuk, AI
    FEBS JOURNAL, 2005, 272 : 143 - 143
  • [10] Impact of gag mutations on selection of darunavir resistance mutations in HIV-1 protease
    Lambert-Niclot, Sidonie
    Flandre, Philippe
    Malet, Isabelle
    Canestri, Ana
    Soulie, Cathia
    Tubiana, Roland
    Brunet, Christel
    Wirden, Marc
    Katlama, Christine
    Calvez, Vincent
    Marcelin, Anne-Genevieve
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 62 (05) : 905 - 908